{"id":55267,"date":"2021-05-21T00:00:00","date_gmt":"2021-05-21T00:00:00","guid":{"rendered":"http:\/\/medgoo.com\/index.php\/2021\/05\/21\/screening-does-not-reduce-ovarian-tubal-cancer-deaths\/"},"modified":"2021-05-25T15:11:09","modified_gmt":"2021-05-25T15:11:09","slug":"screening-does-not-reduce-ovarian-tubal-cancer-deaths","status":"publish","type":"post","link":"https:\/\/medgoo.com\/index.php\/2021\/05\/21\/screening-does-not-reduce-ovarian-tubal-cancer-deaths\/","title":{"rendered":"Screening Does Not Reduce Ovarian, Tubal Cancer Deaths"},"content":{"rendered":"<h3>\n<p>Increase in stage I disease, decrease in stage IV disease incidence seen with multimodal screening versus no screening<\/p>\n<\/h3>\n<p><b><\/b><\/p>\n<p><b><\/b><\/p>\n<p>FRIDAY, May 21, 2021 (HealthDay News) &#8212; Annual screening of postmenopausal women from the general population with multimodal screening or transvaginal ultrasound does not reduce ovarian and tubal cancer deaths, according to a study published online May 12 in <em>The Lancet<\/em>.<\/p>\n<p>Usha Menon, M.D., from University College London, and colleagues conducted a randomized trial involving postmenopausal women aged 50 to 74 years. A total of 202,638 women were recruited and randomly assigned to annual multimodal screening (MMS), annual transvaginal ultrasound screening (USS), or no screening in a 1:1:2 ratio; 202,562 women were included in the analysis. <\/p>\n<p>The researchers found that 2,055 women were diagnosed with tubal or ovarian cancer at a median follow-up of 16.3 years, including 1.0, 1.0, and 1.0 percent of those in the MMS, USS, and no-screening groups, respectively. Compared with no screening, in the MMS group, there was a 47.2 percent increase in stage I and a 24.5 percent decrease in stage IV incidence. The incidence of stage I or II disease was 39.2 percent higher, while the incidence of stage III or IV disease was 10.2 percent lower in the MMS group versus the no-screening group. Overall, 1,206 women died of the disease (0.6 percent in each of the groups). Compared with the no-screening group, there was no significant reduction seen in ovarian and tubal cancer deaths in the MMS or USS groups.<\/p>\n<p>&#8220;Currently, general population screening for ovarian and tubal cancer cannot be recommended,&#8221; the authors write. &#8220;We remain optimistic that further research will develop more effective ways to detect and treat this lethal disease.&#8221;<\/p>\n<p>Several authors disclosed financial ties to the pharmaceutical industry; several authors hold patents related to cancer diagnostics. <\/p>\n<p><a href=\"https:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(21)00731-5\/fulltext\" target=\"_blank\" rel=\"noopener\">Abstract\/Full Text<\/a><\/p>\n<p><a href=\"https:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(21)01061-8\/fulltext\" target=\"_blank\" rel=\"noopener\">Editorial (subscription or payment may be required)<\/a><\/p>\n<p><i><\/i><\/p>\n<p><i>Copyright \u00a9 2021 <a href=\"https:\/\/www.healthday.com\/\" target=\"_new\" rel=\"noopener\">HealthDay<\/a>. All rights reserved.<\/i><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Increase in stage I disease, decrease in stage IV disease incidence seen with multimodal screening versus no screening<\/p>\n","protected":false},"author":6,"featured_media":55468,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[11],"class_list":["post-55267","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"_links":{"self":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/55267","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/comments?post=55267"}],"version-history":[{"count":0,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/55267\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media\/55468"}],"wp:attachment":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media?parent=55267"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/categories?post=55267"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/tags?post=55267"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}